| Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8–risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue … L Marklund, S Holzhauser, C de Flon, M Zupancic, D Landin, A Kolev, ... European Journal of Cancer 139, 192-200, 2020 | 26 | 2020 |
| Long-term survival and recurrence in oropharyngeal squamous cell carcinoma in relation to subsites, HPV, and p16-status M Wendt, L Hammarstedt-Nordenvall, M Zupancic, S Friesland, D Landin, ... Cancers 13 (11), 2553, 2021 | 24 | 2021 |
| Targeted therapy with PI3K and FGFR inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer lines with and without corresponding mutations S Holzhauser, N Wild, M Zupancic, RG Ursu, C Bersani, A Näsman, ... Frontiers in Oncology 11, 640490, 2021 | 24 | 2021 |
| Prognostic markers and driver genes and options for targeted therapy in human-papillomavirus-positive tonsillar and base-of-tongue squamous cell carcinoma A Näsman, S Holzhauser, ON Kostopoulou, M Zupancic, ... Viruses 13 (5), 910, 2021 | 18 | 2021 |
| The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer L Hammarstedt, S Holzhauser, M Zupancic, F Kapoulitsa, RG Ursu, ... Acta Oto-Laryngologica 141 (1), 89-94, 2021 | 14 | 2021 |
| Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma—An Even Broader Tumor Entity? M Zupancic, A Näsman Viruses 13 (9), 1861, 2021 | 13 | 2021 |
| Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer M Mints, D Landin, A Näsman, L Mirzaie, RG Ursu, M Zupancic, ... Scientific Reports 11 (1), 1782, 2021 | 12 | 2021 |
| Targeted therapy of HPV positive and negative tonsillar squamous cell carcinoma cell lines reveals synergy between CDK4/6, PI3K and sometimes FGFR inhibitors, but rarely … ON Kostopoulou, M Zupancic, M Pont, E Papin, M Lukoseviciute, ... Viruses 14 (7), 1372, 2022 | 9 | 2022 |
| Adenoid cystic carcinoma (AdCC): a clinical survey of a large patient cohort M Zupancic, A Näsman, A Berglund, T Dalianis, S Friesland Cancers 15 (5), 1499, 2023 | 6 | 2023 |
| Analysis of human papillomavirus (HPV) and polyomaviruses (HPyVs) in adenoid cystic carcinoma (AdCC) of the head and neck region reveals three HPV-positive cases with adenoid … M Zupancic, S Holzhauser, L Cheng, T Ramqvist, J Du, S Friesland, ... Viruses 14 (5), 1040, 2022 | 6 | 2022 |
| Psoriasin expression is associated with survival in patients with human papillomavirus-positive base of tongue squamous cell carcinoma M Zupancic, L Haeggblom, D Landin, L Marklund, T Dalianis, A Näsman Oncology Letters 21 (4), 1-1, 2021 | 5 | 2021 |
| High levels of FGF11 correlate with poor survival in patients with Human Papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma CH Flon, L Haeggblom, S Holzhauser, ON Kostopoulou, M Zupancic, ... Cancers 15 (7), 1954, 2023 | 4 | 2023 |
| Targeted therapy with PI3K, PARP, and WEE1 inhibitors and radiotherapy in HPV positive and negative tonsillar squamous cell carcinoma cell lines reveals synergy while effects … K Byskata, M Lukoseviciute, F Tuti, M Zupancic, ON Kostopoulou, ... Cancers 15 (1), 93, 2022 | 4 | 2022 |
| Diagnostic and prognostic markers in primarily non-smoking related head and neck cancer M Zupancic PQDT-Global, 2023 | 2 | 2023 |
| Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer L Sivars, C Jylhä, Y Crona Guterstam, M Zupancic, B Lindqvist, ... Clinical Cancer Research, OF1-OF8, 2024 | 1 | 2024 |
| Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status M Lukoceviciute, M Zupancic, ON Kostopoulou, S Holzhauser, T Dalianis Anticancer Research 44 (5), 1863-1876, 2024 | 1 | 2024 |
| Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies M Zupancic, A Näsman, S Friesland, T Dalianis Anticancer Research 44 (4), 1325-1334, 2024 | 1 | 2024 |
| Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly … M Zupancic, ON Kostopoulou, S Holzhauser, M Lukoseviciute, C Jylhä, ... Oral Oncology 151, 106749, 2024 | 1 | 2024 |
| Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report M Zupancic, P Farrajota Neves da Silva, K Kas Elyas, S Friesland, ... Case Reports in Oncology 16 (1), 525-531, 2023 | | 2023 |
| Conclusions: The data suggest that FDA approved drugs alpelisib and erdafitinib efficiently inhibit TSCC/BOTSCC cell line growth, especially when combined irrespective S Holzhauser, N Wild, M Zupancic, RG Ursu, C Bersani, A Näsman, ... FRONTIERS IN ONCOLOGY: EDITOR’S PICK 2021 35, 42, 2022 | | 2022 |
